Clinical trial
Malaria Candidate Vaccines FP9 Circumsporozoite (CS) and MVA CS in Adult Gambian…
NCT00121771 · London School of Hygiene and Tropical Medicine, Other · Completed
Key facts
| NCT number | NCT00121771 |
|---|---|
| Title | Malaria Candidate Vaccines FP9 Circumsporozoite (CS) and MVA CS in Adult Gambian Men |
| Official title | A Phase 1 Trial of the Malaria Candidate Vaccines FP9 CS and MVA CS in Adult Gambian Men Aged 18 - 45 Years |
| Lead sponsor | London School of Hygiene and Tropical Medicine, Other |
| Collaborators | Medical Research Council University of Oxford |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Malaria |
| Intervention type | Biological |
| Interventions | FP9 CS, MVA CS |
| Enrollment | 32 |
| Start date | Jan 1, 2004 |
| Completion | Jul 1, 2004 |
| First posted | Jul 21, 2005 |
| Last update posted | Jan 12, 2017 |
| Countries | The Gambia |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: